Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: Feasibility, outcomes, and estimated cost-effectiveness for palliation

Journal of Vascular and Interventional Radiology

Volumn 23, Issue 6, 2012, Pages 770-777

  Bang, Hyun J ^a   Littrup, Peter J ^b   Goodrich, Dylan J ^b   Currier, Brandt P ^b   Aoun, Hussein D ^b   Heilbrun, Lance K ^b   Vaishampayan, Ulka ^b   Adam, Barbara ^b   Goodman, Allen C ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL METASTASIS; ADULT; ARTICLE; BONE METASTASIS; CANCER CONTROL; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; CRYOABLATION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; LIVER METASTASIS; LUNG METASTASIS; MALE; METASTASIS; NEPHRECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; SURGICAL RISK; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR LOCALIZATION; ULTRASOUND;

CARCINOMA, RENAL CELL; COST-BENEFIT ANALYSIS; CRYOSURGERY; FEASIBILITY STUDIES; FEMALE; HEALTH CARE COSTS; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; METASTASECTOMY; MICHIGAN; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; QUALITY-ADJUSTED LIFE YEARS; RADIOGRAPHY, INTERVENTIONAL; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; YOUNG ADULT;

EID: 84861577031     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2012.03.002     Document Type: Article

References (29)

1. A. Jemal, R. Siegel, J. Xu, E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. M. Ather, N. Masood, T. Siddiqui Current management of advanced and metastatic renal cell carcinoma Urol J 7 2010 1 9
3. J. Thompson-Coon, M. Hoyle, C. Green, Z. Liu, K. Welch, T. Moxham, K. Stein Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation Health Technol Assess 14 2010 1 184
4. S.G. Pauker, J.P. Kassirer Decision analysis N Engl J Med 316 1987 250 258 (Pubitemid 17051051)
5. J.C. Yang, L. Haworth, R.M. Sherry A randomised trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer New Engl J Med 349 2003 427 434 (Pubitemid 36910021)
6. B. Escudier, A. Pluzanska, P. Koralewski Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial Lancet 370 2007 2103 2111 (Pubitemid 350296300)
7. Rini BI, Halabi S, Rosenberg JE, et al. CALGB 90206: a phase III trial of bevacizumab plus interferon-alpha versus interferon-alpha monotherapy in metastatic renal cell carcinoma. In: 2008 ASCO Genitourinary Cancers Symposium Proceedings. Abstract 350.
8. S. Chowdhury, J.M.G. Larkin, M.E. Gore Recent advances in the treatment of renal cell carcinoma and the role of targeted therapies Eur J Cancer 44 2008 2152 2161
9. H.S. Hofmann, H. Neef, K. Krohe, P. Andreev, R.E. Silber Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma Eur Urol 48 2005 77
10. S.E. Eggener, O. Yossepowitch, S. Kundu, R.J. Motzer, P. Russo Risk score and metastasectomy independently impact prognosis in patients with recurrent renal cell carcinoma J Urol 180 2008 873 878
11. G.A. Porter, S.B. Cantor, G.L. Walsh Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers J Thorac Cardiovasc Surg 127 2004 1366 1372 (Pubitemid 38560599)
12. S. Naito, N. Yamamoto, T. Takayama Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients Eur Urol 57 2010 317 325
13. P.V. Pandharipande, G.S. Gazelle Comparative effectiveness research: What it means for radiology Radiology 253 2009 600 605
14. M.E. Allaf, I.M. Varkarakis, S.B. Bhayani, T. Inagaki, L.R. Kavoussi, S.B. Solomon Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation - initial observations Radiology 237 2005 366 370 (Pubitemid 41346189)
15. P.J. Littrup, A. Ahmed, H.D. Aoun CT-guided percutaneous cryotherapy of renal masses J Vasc Interv Radiol 18 2007 383 392 (Pubitemid 46628946)
16. H. Wang, P.J. Littrup, Y. Duan Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures Radiology 235 2005 289 298 (Pubitemid 40432266)
17. P.J. Littrup, B. Jallad, P. Chandiwala-Mody, M. D'Agostini, B.A. Adam, D. Bouwman Cryotherapy for breast cancer: a feasibility study without excision J Vasc Interv Radiol 20 2009 1329 1341
18. P.J. Littrup, B. Jallad, V. Vorugu, G. Littrup, B. Currier, M. George, D. Herring Lethal isotherms of cryoablation in a phantom study: effects of heat load, probe size, and number J Vasc Interv Radiol 20 2009 1343 1351
19. E. Lee, J.W. Wang Statistical methods for survival data analysis 3rd ed. 2003 Wiley Hoboken, NJ
20. P.V. Pandharipande, D.A. Gervais, R.I. Hartman Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis Radiology 256 2010 836 846
21. P.V. Pandharipande, D.A. Gervais, P.R. Mueller, C. Hur, G.S. Gazelle Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis Radiology 248 2008 169 178
22. G.S. Gazelle, P.M. McMahon, M.T. Beinfeld, E.F. Halpern, M.C. Weinstein Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection Radiology 233 2004 729 739
23. P. Mouracade, H. Dettloff, M. Schneider, B. Debras, J.L. Jung Radio-frequency ablation of solitary adrenal gland metastasis from renal cell carcinoma Urology 74 2009 1341 1343
24. R.S. Arellano, V.L. Flanders, S.I. Lee, P.R. Mueller, D.A. Gervais Imaging-guided percutaneous radiofrequency ablation of retroperitoneal metastatic disease in patients with gynecologic malignancies: clinical experience with eight patients AJR Am J Roentgenol 194 2010 1635 1638
25. C.J. Simon, D.E. Dupuy, T.A. DiPetrillo Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients Radiology 243 2007 268 275 (Pubitemid 46579719)
26. R. Lencioni, L. Crocetti, R. Cioni Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study) Lancet Oncol 9 2008 621 628
27. N. Soga, K. Yamakado, H. Gohara Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma BJU Int 104 2009 790 794
28. A. Shu Yan Huo, D. Lawson Morris, J. King, D. Glenn Use of percutaneous radiofrequency ablation in pulmonary metastases from renal cell carcinoma Ann Surg Oncol 16 2009 3169 3175
29. S. Folland, A.C. Goodman, M. Stano Cost benefit analysis and other tools of economic evaluation S. Folland, A.C. Goodman, M. Stano, The Economics of Health and Health Care 6th ed. 2010 Prentice Hall Upper Saddle River, NJ 74 96